Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 103 The United Laboratories International Holdings Limited Annual Report 2022 13. DIRECTORS’ AND CHIEF EXECUTIVE’S EMOLUMENTS (Continued) 2021 (a) Executive directors Tsoi Leung Choy Fang Zou Zhu Hoi Shan Wing Hon Siu Chit Yu Ping Xian Hong Su Yan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Fees – – – – – – – Other emoluments Salaries and other benefits 3,674 3,564 2,658 1,610 1,610 1,610 14,726 Bonus – 99 – 720 720 720 2,259 Contributions to retirement benefit schemes 15 15 15 36 – – 81 Sub-total 3,689 3,678 2,673 2,366 2,330 2,330 17,066 The executive directors’ emoluments shown above were for their services in connection with the management of the affairs of the Company and the Group. (b) Independent non-executive directors Chong Song Fu Peng Oon Ming Xiao Nan Total RMB’000 RMB’000 RMB’000 RMB’000 Fees 210 210 210 630 The independent non-executive directors’ emoluments shown above were for their services as directors of the Company. Total 17,696